Business Context and Reporting Period
Company: Amgen Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2025
Reporting Period: Third Quarter and nine months ended September 30, 2025.
This filing announces the issuance of a press release containing unaudited results of operations and financial position. The report includes both GAAP and non-GAAP financial measures to facilitate investor analysis of ongoing business activities.
Key Financial Metrics
Note: The provided text describes the methodology for financial reporting but does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue & Profit: Specific GAAP and non-GAAP revenue, operating income, and earnings per share figures are not listed in this filing text; they are referenced as being contained in the attached press release (Exhibit 99.1).
- Cash Flow: The company reports Free Cash Flow (FCF), calculated as operating cash flow minus capital expenditures, as a measure of liquidity.
- Non-GAAP Adjustments: The filing details exclusions from GAAP measures, including acquisition-related expenses, restructuring charges, and other unusual items.
Material Changes and Non-GAAP Reconciliations
The filing outlines specific items excluded from GAAP results to calculate non-GAAP metrics, which may impact period-over-period comparisons:
- Acquisition-Related Expenses: Excludes amortization and impairment of intangible assets (e.g., technology rights, licensing rights) and step-up to fair value of acquired inventory. These vary based on acquisition timing and magnitude.
- Restructuring and Cost Savings: Excludes facility charges, asset impairments, accelerated depreciation, and severance/benefits related to transformation efforts.
- Other Items: Excludes gains/losses on equity securities and certain legal proceeding items deemed outside the ordinary course of business.
- Tax Effects: Adjustments account for the specific tax treatment and rates applicable to each excluded item in relevant jurisdictions.
Guidance, Outlook, and Management Commentary
Management Use of Metrics: Management utilizes non-GAAP measures for internal budgeting, financial planning, resource allocation, and evaluating performance against incentive compensation targets. The company asserts these measures provide a supplemental evaluation of current operating performance and facilitate comparisons across periods.
Forward-Looking Information: The filing text does not contain specific forward-looking guidance, numerical outlooks, or detailed risk factors beyond the standard disclaimer that the press release information is not "filed" under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific numerical values regarding Q3 2025 revenue, net income, and EPS, as they are not present in the 8-K text.
- Verify the reconciliation tables in the press release to understand the magnitude of adjustments between GAAP and non-GAAP results.
- Assess the impact of acquisition-related amortization and restructuring charges on the reported margins.
- Confirm the calculation of Free Cash Flow as defined by the company (Operating Cash Flow less Capital Expenditures).